PELOBiotech presents CellCorTM line at ATMP conference.
Biotechnology company PELOBiotech will present new stem cell research products at the ATMP 2022 conference in Frankfurt, Germany, May 17-18.
With the theme "Advanced Therapies - Challenges for Routine Applications," ATMP 2022 will kick off in Frankfurt on May 17-18, 2022. As one of the world's leading suppliers of animal and human cells and media, the company PELOBiotech, from Planegg near Munich, will present the CellCorTM line.
Launched in Europe almost a year ago, this chemically defined medium line from Korea's Xcell Therapeutics is ideally suited for mesenchymal stem cells (MSCs) and is available as a chemically defined MSC medium CellCorTM CD. By offering this new product, the company is pushing stem cell research far forward.
These, as well as over 20,000 life science products offered, are offered by the company in R&D quality and some in GMP quality. There is no need for extensive storage and the associated costs, as the products are generally available in stock, i.e. within 48 hours, within Germany and Austria.
Dr. Lothar Steeb, CSO &CEO and Dr. Ingrid Kautner, Account Manager (for the region) are looking forward to questions and lively exchange from interested visitors on May 17-18 in Frankfurt.